Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Personalized Medicine|February 16, 2019
Metabolomic diagnostics and human digital imageElena E Balashova, Petr G Lokhov, Elena A Ponomarenko, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2021
High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosisVasily A Kudinov, Tatiana I Torkhovskaya, Tamara S Zakharova, et al.
International Journal of Molecular Sciences|November 24, 2020
High-Density Lipoproteins as Homeostatic Nanoparticles of Blood PlasmaVasily A Kudinov, Olga Yu Alekseeva, Tatiana I Torkhovskaya, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Metabolomic Markers for Predicting Preeclampsia in the First Trimester of Pregnancy: A Retrospective StudyEkaterina V Ilgisonis, Raisa Shalina, Nigyar Kasum-Zade, et al.
International Journal of Molecular Sciences|August 26, 2022
Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury ModelSergey S Markin, Roman D Lapshin, Olga S Baskina, et al.
The Lancet. Neurology|August 21, 2021
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trialEugene I Gusev, Mikhail Yu Martynov, Alexey A Nikonov, et al.
Journal of Thrombosis and Thrombolysis|November 16, 2025
Prognostic outcome of intravenous thrombolysis with non-immunogenic staphylokinase in patients aged ≥ 60 years with acute ischemic stroke by THRIVE scaleNikolay A Shamalov, Zhanna Yu Chefranova, Elena B Yarovaya, et al.
Stroke|November 26, 2025
Thrombolysis With the Nonimmunogenic Staphylokinase for Acute Ischemic Stroke in FORPI Registry: An Observational StudyNikolay A Shamalov, Mikhail Yu Martynov, Elena B Yarovaya, et al.
Health Science Reports|May 20, 2025
The Safety of Non-immunogenic Recombinant Staphylokinase in Elderly Patients With Massive Pulmonary Embolism: A Randomized Clinical Trial FORPEStanislav G Leontyev, Elena B Yarovaya, Vladimir A Kutsenko, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2024
Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPEAlexander I Kirienko, Stanislav G Leontyev, Sergey N Tereschenko, et al.
Pageof 2